Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The lack of effective treatment options for chronic neurological conditions, such as multiple sclerosis (MS), highlights the need to re-evaluate disease pathophysiology in the process of identifying novel therapeutic targets. The persistent activation of mononuclear phagocytes (MPs) is one of the major drivers of neurodegeneration and it sustains central nervous system (CNS) damage. Mitochondrial metabolism influences the activity of MPs, and the metabolites that they produce have key signalling roles in inflammation. However, how changes in immune cell metabolism sustain a chronic state of neuroinflammation is not fully understood. Novel molecular and cellular therapies for chronic neuroinflammation should be developed to target mitochondrial metabolism in innate immune cells to prevent secondary neurological damage and the accumulation of irreversible disability in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · cited 1×
“This first classification was in part based on one important metabolic feature: M1 macrophages produce nitric oxide (NO), whereas M2 macrophages produce polyamines [27].”
BackgroundFunctional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Chouchani, E. T., Pell, V. R., Gaude, E., Aksentijević, D., Sundier, S. Y., Robb, E. L., Logan, A., Nadtochiy, S. M., Ord, E. N. J., Smith, A. C., et al. (2014) · Nature · doi:10.1038/nature13909 · Cited by 2,907
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“5) for susceptibility to late-onset AD [125].”
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491 · cited 1×
“neuronal death occurs secondarily to a type of myelin loss evolving on a background of inflammation, comprising T lymphocytes, B lymphocytes, and plasma cells [11,12].”
BackgroundMacrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384 · cited 1×
“Anti-inflammatory mouse macrophages are characterised by high levels of arginase-1 activity, which is needed to metabolise arginine to proline, a component of collagen that is required for tissue repair and resolution of inflammation [134].”
BackgroundATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298 · cited 4×
“Cytosolic acetylCoA is used for histone acetylation, thereby increasing the transcription of glycolytic genes, such as those encoding hexokinase 2, phosphofructokinase, and LDH [56].”
MethodInfluentialMills, E. L., Kelly, B., Logan, A., Costa, A. S. H., Varma, M., Bryant, C. E., Tourlomousis, P., Däbritz, J. H. M., Gottlieb, E., Latorre, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.064 · Cited by 2,291 · cited 7×
“Abbreviations: ACL, ATP-citrate lyase; C, mitochondrial complex; CAD, cis-aconitate decarboxylase 1; CIC, citrate carrier; ER, endoplasmic reticulum; FA, fatty acid; G6P, glucose 6-phosphate; G6PD, glucose-6-phosphate dehydrogenase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GLUT1, glucose transporter type 1; ID…”
BackgroundInfluentialPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · cited 1×
“MS Therapeutics and Their Effect on Mitochondrial Metabolism Cell metabolism is emerging as a highly relevant therapeutic target to interfere with the activation of both macrophages [75] and microglia [76] and possibly with the accumulation of irreversible disabilities in patients with chronic neuroinflammatory diseas…”
BackgroundJha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008 · cited 1×
“Conversely, higher NAD/NADH ratios influence the activities of the class III HDACs sirtuin 1 and 6, which use oxidised NAD as a substrate for not only the deacetylation process, but also the inhibition of the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and protein lysine…”
BackgroundMicroglia and macrophages in brain homeostasis and disease
Li, Q., & Barres, B. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.125 · Cited by 1,999 · cited 1×
“, CX3CR1 and CD11b), and only recently have specific markers indicative of a microglial homeostatic signature, such as the transmembrane protein 119 (TMEM119), the P2Y purinoceptor 12 (P2RY12), and the Sal-like protein 1 (SALL1), been described [128,129].”
BackgroundItaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885 · cited 8×
“AHR Itaconate NRF2 IFNs GAPDH TNF-α Figure 2.”
BackgroundInfluentialMetabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876 · cited 1×
“MS Therapeutics and Their Effect on Mitochondrial Metabolism Cell metabolism is emerging as a highly relevant therapeutic target to interfere with the activation of both macrophages [75] and microglia [76] and possibly with the accumulation of irreversible disabilities in patients with chronic neuroinflammatory diseas…”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“In progressive MS, the extent of MP activation is further increased by retrograde neurodegeneration after axonal damage in white matter lesions [20,21].”
BackgroundOxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
Liu, P.-S., Wang, H., Li, X., Chao, T., Teav, T., Christen, S., Di Conza, G., Cheng, W.-C., Chou, C.-H., Vavakova, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3796 · Cited by 1,264
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., Binz, T., Wegner, A., Tallam, A., Rausell, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218599110 · Cited by 1,191 · cited 1×
“Cis-aconitate is converted by the enzyme cis-aconitate decarboxylase 1 (CAD), coded by immunoresponsive gene 1 (Irg1) to itaconate [42,43], which has major antimicrobial activity (e.”
MethodLinker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa
Dantzer, R. (2018) · Physiological Reviews · doi:10.1152/physrev.00039.2016 · Cited by 1,073 · cited 2×
“In this perspective, exogenous stem cell therapeutics may overcome most of these limitations for small molecules and biologics, being de facto capable of adapting their own phenotype and function, while secreting and uptaking multiple therapeutic small molecules in response to the local tissue microenvironment [111,11…”
BackgroundMuller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064 · cited 1×
“Cell competition is a well-established model in cancer, where tumour cells consume high levels of glucose and release lactate and the tryptophan-metabolising enzyme indoleamine 2,3-dioxygenase (IDO), to mediate local immunosuppression in the tumour microenvironment via the consumption of tryptophan and release of kynu…”
BackgroundMicroglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051 · cited 2×
“In turn, microglia-derived transforming growth factor (TGF)-a signalling limits the activity of neurotoxic A1 astrocytes in mice with experimental autoimmune encephalomyelitis (EAE), as a model of MS [62].”
BackgroundKetone bodies as signaling metabolites
Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966 · cited 1×
“Ketone bodies, such as the beta-hydroxybutyrate (BHOB), which are produced from the liver after food deprivation [63], also have major anti-inflammatory effects via hydrocarboxylic acid receptor 2-HCAR2 (GPR109A) signalling on mouse BMDMs and human monocytes in vitro, and in mouse models of NLR family pyrin domain-con…”
BackgroundMitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960
Lassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937 · cited 1×
“neuronal death occurs secondarily to a type of myelin loss evolving on a background of inflammation, comprising T lymphocytes, B lymphocytes, and plasma cells [11,12].”
BackgroundArts, R. J. W., Novakovic, B., ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S.-C., Wang, S.-Y., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.008 · Cited by 930 · cited 2×
“As consequence, a distinct DNA and histone hypermethylation profile is observed in SDH and fumarase hydratase-deficient tumours, where succinate and fumarate accumulate, respectively, and in IDH mutant tumours, where 2HG accumulates [58].”
BackgroundCitric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909 · cited 1×
“Extracellular succinate acts on the succinate receptor SUCNR1/GPR91, a G-protein-coupled cell surface sensor with pleiotropic roles in different tissues and/or organs [68] that has a key functional role in mast cells [69], dendritic cells (DCs) [70], monocytes [71], and macrophages/ microglia within the immune system…”
BackgroundLatent Enhancers Activated by Stimulation in Differentiated Cells
Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S., Curina, A., Prosperini, E., Ghisletti, S., & Natoli, G. (2013) · Cell · doi:10.1016/j.cell.2012.12.018 · Cited by 867
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Brandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L. P., Park, R., Vinciguerra, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.012 · Cited by 850
Microglia: Scapegoat, saboteur, or something else?
Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836 · cited 1×
“These resident MPs include both microglia, which constitute 5–10% of total brain cells and are the only true CNS parenchymal MPs [7], and macrophages, which reside in the perivascular spaces, the leptomeninges, and the choroid plexus [8].”
BackgroundDistinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Frischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728 · cited 2×
“Smouldering plaques are frequently and almost exclusively found in progressive MS [18], and represent the slow expansion of pre-existing lesions now characterised by the accumulation of inflammatory MPs leading to active demyelination [16,19].”
BackgroundElectrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis
Bambouskova, M., Gorvel, L., Lampropoulou, V., Sergushichev, A., Loginicheva, E., Johnson, K., Korenfeld, D., Mathyer, M. E., Kim, H., Huang, L.-H., et al. (2018) · Nature · doi:10.1038/s41586-018-0052-z · Cited by 713
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity
Kornberg, M. D., Bhargava, P., Kim, P. M., Putluri, V., Snowman, A. M., Putluri, N., Calabresi, P. A., & Snyder, S. H. (2018) · Science · doi:10.1126/science.aan4665 · Cited by 687 · cited 1×
“Recent data also suggest that the main mechanism of action of DMF in RR MS depends on the succination and inactivation of the catalytic cysteine of the glycolytic enzyme GAPDH, thereby downregulating aerobic glycolysis in activated myeloid and lymphoid cells [82].”
BackgroundLoss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 4×
“Smouldering plaques are frequently and almost exclusively found in progressive MS [18], and represent the slow expansion of pre-existing lesions now characterised by the accumulation of inflammatory MPs leading to active demyelination [16,19].”
BackgroundInfluentialRevisiting the Mechanisms of CNS Immune Privilege
Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682 · cited 1×
“However, the presence of a functional meningeal lymphatic system (see Glossary) in the CNS suggests that current dogmas regarding brain tolerance and the immune privilege of the brain should be revisited [2], and highlights a close relationship between the CNS and immune system in both health and disease [3,4].”
BackgroundHeterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674 · cited 1×
“The activation of CNS-resident MPs, and especially that of microglial cells, is a salient feature of the neuroinflammation that is prominent in almost all neurodegenerative diseases, including Alzheimer’s disease (AD) (Box 1), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) [9,10].”
BackgroundThe Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism
Haschemi, A., Kosma, P., Gille, L., Evans, C. R., Burant, C. F., Starkl, P., Knapp, B., Haas, R., Schmid, J. A., Jandl, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.023 · Cited by 635 · cited 10×
“Anti-inflammatory macrophages downregulate flux through the PPP by inducing CARKL, which inhibits this pathway, resulting in reduced NADPH-mediated glutathione levels [36].”
BackgroundInfluentialVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621 · cited 1×
“This worsens the unsteady balance between the energy demands and supply, thus inducing a chronic state of virtual hypoxia in chronically demyelinated axons [22].”
BackgroundSall1 is a transcriptional regulator defining microglia identity and function
Buttgereit, A., Lelios, I., Yu, X., Vrohlings, M., Krakoski, N. R., Gautier, E. L., Nishinakamura, R., Becher, B., & Greter, M. (2016) · Nature Immunology · doi:10.1038/ni.3585 · Cited by 570
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-Perrig, N., Schwärzler, C., Junt, T., Voshol, H., Meingassner, J. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1657 · Cited by 525 · cited 2×
“Extracellular succinate acts on the succinate receptor SUCNR1/GPR91, a G-protein-coupled cell surface sensor with pleiotropic roles in different tissues and/or organs [68] that has a key functional role in mast cells [69], dendritic cells (DCs) [70], monocytes [71], and macrophages/ microglia within the immune system…”
BackgroundMacrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479 · cited 2×
“In relapsing remitting (RR) MS, active lesions predominate and the most common lesion types (patterns I and II) [14] show a diffuse perivascular and parenchymal T cell infiltration and a background of MPs. MPs are also present in the normal-appearing white matter (NAWM) and, in both cases, they express proinflammatory…”
BackgroundNagy, E., & Rigby, W. F. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2755 · Cited by 361
Kelly, B., Tannahill, G. M., Murphy, M. P., & O'Neill, L. A. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662114 · Cited by 334
Metabolic regulation of inflammation
Gaber, T., Strehl, C., & Buttgereit, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.37 · Cited by 320 · cited 3×
“Second, mTOR activation upregulates lipid synthesis [47] and the NADPH derived from the PPP is used as a co-factor for de novo FAS, ultimately favouring the expansion of the endoplasmic reticulum (ER) and Golgi to support cytokine secretion [24] (Figure 1).”
BackgroundArginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells
Raes, G., Van den Bergh, R., De Baetselier, P., & Ghassabeh, G. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6561 · Cited by 302
Peruzzotti-Jametti, L., Bernstock, J. D., Vicario, N., Costa, A. S. H., Kwok, C. K., Leonardi, T., Booty, L. M., Bicci, I., Balzarotti, B., Volpe, G., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.01.020 · Cited by 285
Self-citationSmith, A. M., & Dragunow, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.001 · Cited by 256 · cited 1×
“Proinflammatory MPs also impair glutamate transport in astrocytes, which in turn further increases the extent of direct neuronal and oligodendrocyte excitotoxicity [23].”
BackgroundHuman neural stem cells ameliorate autoimmune encephalomyelitis in non‐human primates
Pluchino, S., Gritti, A., Blezer, E., Amadio, S., Brambilla, E., Borsellino, G., Cossetti, C., Del Carro, U., Comi, G., 't Hart, B., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21745 · Cited by 208
Self-citationReview: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193 · cited 1×
“For example, potentiating oxidative phosphorylation and the TCA cycle might have dual beneficial effects in progressive MS by reverting energy deficiency in neurons [122], while counteracting the Warburg effect in MPs.”
BackgroundMetabolism Supports Macrophage Activation
Langston, P. K., Shibata, M., & Horng, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00061 · Cited by 185 · cited 1×
“Nonetheless, these initial studies have highlighted a key concept in MP biology: the link between MP activation and metabolism [31].”
BackgroundMitochondrial metabolites: undercover signalling molecules
Frezza, C. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0100 · Cited by 136 · cited 1×
“These ‘immunometabolites’ function both as intracellular signalling molecules [48], as well as extracellular signals of inflammation, acting as de facto ‘metabokines’ (Figure 2).”
BackgroundExtracellular vesicles are independent metabolic units with asparaginase activity
Iraci, N., Gaude, E., Leonardi, T., Costa, A. S. H., Cossetti, C., Peruzzotti-Jametti, L., Bernstock, J. D., Saini, H. K., Gelati, M., Vescovi, A. L., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2422 · Cited by 134
Self-citationFood Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense
Luan, H. H., & Medzhitov, R. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.013 · Cited by 130 · cited 1×
“Extracellular metabolites can also act as key signalling molecules, both at the organismal level and within specific inflammatory microenvironments [61].”
BackgroundDimethyl Itaconate Is Not Metabolized into Itaconate Intracellularly
ElAzzouny, M., Tom, C. T. M. B., Evans, C. R., Olson, L. L., Tanga, M. J., Gallagher, K. A., Martin, B. R., & Burant, C. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.c117.775270 · Cited by 125
The REM phase of gene regulation
Hentze, M. W., & Preiss, T. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.009 · Cited by 115
The formation of inflammatory demyelinated lesions in cerebral white matter
Maggi, P., Macri, S. M. C., Gaitán, M. I., Leibovitch, E., Wholer, J. E., Knight, H. L., Ellis, M., Wu, T., Silva, A. C., Massacesi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24242 · Cited by 110 · cited 1×
“In mice with EAE, resident MPs appear to have a key pathogenic role, because early changes in vascular permeability are associated with perivascular inflammatory cuffing and parenchymal microglial activation that precede the arrival of blood-derived monocytes accompanying demyelination [130].”
BackgroundStromal cell niches in the inflamed central nervous system.
Pikor, N. B., Cupovic, J., Onder, L., Gommerman, J. L., & Ludewig, B. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601566 · Cited by 33 · cited 1×
“As such, the progressive exhaustion of NSCs within brain germinal niches, as a major component of brain aging and related diseases, is being proposed as a possible explanation of the emerging connection between metabolic dysfunction, anatomical and structural damage, depression, and other cognitive and mental health p…”
BackgroundDimethyl fumarate: targeting glycolysis to treat MS
Angiari, S., & O’Neill, L. A. (2018) · Cell Research · doi:10.1038/s41422-018-0045-3 · Cited by 27 · cited 1×
“Identification of the metabolic determinants of such a steady activation of CNS-compartmentalised innate immune responses might help pinpoint a range of druggable metabolic pathways through which to reduce neuroinflammation, reducing concomitant neurodegeneration and the accumulation of irreversible disabilities in pa…”
Background
Cited by
Glycolysis – a key player in the inflammatory response
Soto‐Heredero, G., Gómez de las Heras, M. M., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · The FEBS Journal · doi:10.1111/febs.15327 · Cited by 641
Lin, M.-M., Liu, N., Qin, Z.-H., & Wang, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00879-6 · Cited by 315
Mitochondrial Dysfunction and Multiple Sclerosis
Barcelos, I. P. D., Troxell, R. M., & Graves, J. S. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 291
Neural stem cells traffic functional mitochondria via extracellular vesicles
Peruzzotti-Jametti, L., Bernstock, J. D., Willis, C. M., Manferrari, G., Rogall, R., Fernandez-Vizarra, E., Williamson, J. C., Braga, A., van den Bosch, A., Leonardi, T., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001166 · Cited by 263
“desirable, such as in neuroinflammation [9,73,74], or block its occurrence when it is deleterious [75].”
BackgroundSelf-citationMitochondrial complex I activity in microglia sustains neuroinflammation
Peruzzotti-Jametti, L., Willis, C. M., Krzak, G., Hamel, R., Pirvan, L., Ionescu, R.-B., Reisz, J. A., Prag, H. A., Garcia-Segura, M. E., Wu, V., et al. (2024) · Nature · doi:10.1038/s41586-024-07167-9 · Cited by 239
Self-citation
Metadata
- Authors
- Peruzzotti-Jametti, L., & Pluchino, S.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 24
- Issue
- 10
- Pages
- 838-855
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2887456892
- Cited by
- 75
- References
- 66
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.